AAAAAA

   
Results: 1-17 |
Results: 17
Constitutive activation of the Wnt signaling pathway by CTNNBI (beta-catenin) mutations in a subset of human lung adenocarcinoma
Authors: Sunaga, N Kohno, T Kolligs, FT Fearon, ER Saito, R Yokota, J
Citation: N. Sunaga et al., Constitutive activation of the Wnt signaling pathway by CTNNBI (beta-catenin) mutations in a subset of human lung adenocarcinoma, GENE CHROM, 30(3), 2001, pp. 316-321
Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas
Authors: Wu, R Zhai, Y Fearon, ER Cho, KR
Citation: R. Wu et al., Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas, CANCER RES, 61(22), 2001, pp. 8247-8255
Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon
Authors: Hinoi, T Tani, M Lucas, PC Caca, K Dunn, RL Macri, E Loda, M Appelman, HD Cho, KR Fearon, ER
Citation: T. Hinoi et al., Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon, AM J PATH, 159(6), 2001, pp. 2239-2248
Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles
Authors: Giordano, TJ Shedden, KA Schwartz, DR Kuick, R Taylor, JMG Lee, N Misek, DE Greenson, JK Kardia, SLR Beer, DG Rennert, G Cho, KR Gruber, SB Fearon, ER Hanash, S
Citation: Tj. Giordano et al., Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles, AM J PATH, 159(4), 2001, pp. 1231-1238
BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer-association or mechanism?
Authors: Fearon, ER
Citation: Er. Fearon, BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer-association or mechanism?, J NAT CANC, 92(7), 2000, pp. 515-517
Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subsetof pancreatic and biliary cancers
Authors: Hilgers, W Song, JJ Haye, M Hruban, RR Kern, SE Fearon, ER
Citation: W. Hilgers et al., Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subsetof pancreatic and biliary cancers, GENE CHROM, 27(4), 2000, pp. 353-357
gamma-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin
Authors: Kolligs, FT Kolligs, B Hajra, KM Hu, G Tani, M Cho, KR Fearon, ER
Citation: Ft. Kolligs et al., gamma-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin, GENE DEV, 14(11), 2000, pp. 1319-1331
Regulation of beta-catenin transformation by the p300 transcriptional coactivator
Authors: Sun, YN Kolligs, FT Hottiger, MO Mosavin, R Fearon, ER Nabel, GJ
Citation: Yn. Sun et al., Regulation of beta-catenin transformation by the p300 transcriptional coactivator, P NAS US, 97(23), 2000, pp. 12613-12618
E-cadherin is a WT1 target gene
Authors: Hosono, S Gross, I English, MA Hajra, KM Fearon, ER Licht, JD
Citation: S. Hosono et al., E-cadherin is a WT1 target gene, J BIOL CHEM, 275(15), 2000, pp. 10943-10953
beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer
Authors: Caca, K Kolligs, FT Ji, XD Hayes, M Qian, JM Yahanda, A Rimm, DL Costa, J Fearon, ER
Citation: K. Caca et al., beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer, CELL GROWTH, 10(6), 1999, pp. 369-376
Netrin-1: Interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas
Authors: Meyerhardt, JA Caca, K Eckstrand, BC Hu, G Lengauer, C Banavali, S Look, AT Fearon, ER
Citation: Ja. Meyerhardt et al., Netrin-1: Interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas, CELL GROWTH, 10(1), 1999, pp. 35-42
Primer - Cancer progression
Authors: Fearon, ER
Citation: Er. Fearon, Primer - Cancer progression, CURR BIOL, 9(23), 1999, pp. R873-R875
Cancer genetics: Tumor suppressor meets oncogene
Authors: Fearon, ER Dang, CV
Citation: Er. Fearon et Cv. Dang, Cancer genetics: Tumor suppressor meets oncogene, CURR BIOL, 9(2), 1999, pp. R62-R65
Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements
Authors: Hajra, KM Ji, XD Fearon, ER
Citation: Km. Hajra et al., Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements, ONCOGENE, 18(51), 1999, pp. 7274-7279
Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression
Authors: Kolligs, FT Hu, G Dang, CV Fearon, ER
Citation: Ft. Kolligs et al., Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression, MOL CELL B, 19(8), 1999, pp. 5696-5706
Siah-1 N-terminal RING domain is required for proteolysis function, and C-terminal sequences regulate oligomerization and binding to target proteins
Authors: Hu, G Fearon, ER
Citation: G. Hu et Er. Fearon, Siah-1 N-terminal RING domain is required for proteolysis function, and C-terminal sequences regulate oligomerization and binding to target proteins, MOL CELL B, 19(1), 1999, pp. 724-732
Frequent Nuclear/Cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma
Authors: Rimm, DL Caca, K Hu, G Harrison, FB Fearon, ER
Citation: Dl. Rimm et al., Frequent Nuclear/Cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma, AM J PATH, 154(2), 1999, pp. 325-329
Risultati: 1-17 |